Rx Rundown: Pfizer, Mirum Pharmaceuticals, Novartis and more
Deals: Pfizer entered into an exclusive licensing agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical, which could be worth almost $2 billion. Novartis agreed to pay Relation Therapeutics as much as $1.7 billion in a pact. Crescent …